China Respiratory Devices Market Outlook 2031:
The china respiratory devices market size was valued at USD 2.62 Billion in 2022 and is projected to reach USD 4.82 Billion by 2031, expanding at a CAGR of 7% during the forecast period 2023 - 2031. The respiratory devices supply respiratory air automatically to people with reduced respiratory concern. The respiratory gas is usually enhanced by oxygen and delivered inside the lung with a certain pressure created in the device.
The ventilator fully affects pressures and volumes. While in aided respiration the respiratory device simply provides the mechanical breathing attempts with an established overpressure.
The Covid-19 pandemic affected the demand and supply of China respiratory devices market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.
China Respiratory Devices Market Trends, Drivers, Restraints, and Opportunities
- Increasing investments by hospitals is projected to boost the market in the coming years.
- Introduction of technological and novel advanced products is the major factor fueling the market.
- Emerging economies and lack of health infrastructure is anticipated to restrict the market growth.
- Lack of awareness about respiratory devices present a main challenge that can hamper the market expansion during the forecast period.
- R&D investment and technological advancement in respiratory devices market is projected to offer lucrative opportunities for the market players.
Scope of the China Respiratory Devices Market Report
The report on the China respiratory devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
China Respiratory Devices Market–Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016-2021
|
|
Forecast Period
|
2023-2031
|
|
Segmentation
|
Types (Diagnostic & Monitoring Devices [Pulse Oximeter, Sleep Test Devices, Spirometers, Capnographs, Peak Flow Meters, and Others], Therapeutic Devices [BiPAP Devices, Inhalers, Nebulizers, CPAP Devices, Humidifiers, Ventilators, Oxygen Concentrators, and Others], and Disposables [Breathing Circuits, Masks, and Others]), End-users (Home Care, Hospitals, and Ambulatory Care Centres)
|
|
Country
|
China
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players covered in the Report
|
Vincent Medical; Medtronic PLC; GlaxoSmithKline PLC; Fisher & Paykel Healthcare Ltd; DeVilbiss Healthcare LLC; GE Healthcare; Dragerwerk AG; Koninklijke Philips NV; and ResMed Inc.
|
China Respiratory Devices Market Segment Insights
The therapeutic devices segment accounts for key share of the market
Based on types, the China respiratory devices market is divided into diagnostic & monitoring devices, therapeutic devices, and disposables. The diagnostic & monitoring spirometers devices segment are sub-segmented into pulse oximeter, sleep test devices, spirometers, capnographs, peak flow meters, and others.
The therapeutic devices segment is sub-segmented into BiPAP devices, inhalers, nebulizers, CPAP devices, humidifiers, ventilators, oxygen concentrators, and others. The disposables segment is sub-segmented into breathing circuits, masks, and others. The therapeutic devices accounts for a key share of the market. Growth of the market is attributed to technological advancement in healthcare sector and increasing per capita income.
However, the diagnostic & monitoring devices segment is anticipated to expand at a rapid pace during the forecast period due to factors such as rising demand for respiratory devices in private hospitals and increasing availability of trained professionals.
The hospitals segment accounts for significant share of the market
On the basis of end-users, the market is categorized into home care, hospitals, and ambulatory care centres. The hospital segment accounts for a significant share of the market. Growth of the market attributed to increasing prevalence of respiratory disorders and rapid advancement in respiratory devices.
The ambulatory care centres segment is anticipated to expand at a rapid pace during the forecast period due to factors such as increasing demand for inhalers and rapid urbanization.
Segments
The China respiratory devices market has been segmented on the basis of
Types
End-users
- Home Care
- Hospitals
- Ambulatory Care Centers
Country
Key Players
- Vincent Medical
- Medtronic PLC
- GlaxoSmithKline PLC
- Fisher & Paykel Healthcare Ltd
- DeVilbiss Healthcare LLC
- GE Healthcare
- Dragerwerk AG
- Koninklijke Philips NV
- ResMed Inc.
Competitive Landscape
Key players competing in the China respiratory devices market include Vincent Medical; Medtronic PLC; GlaxoSmithKline PLC; Fisher & Paykel Healthcare Ltd; DeVilbiss Healthcare LLC; GE Healthcare; Dragerwerk AG; Koninklijke Philips NV; and ResMed Inc.
Some of these players are using several market strategies such as acquisitions, merger, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares and to generate revenue and rise their production line of the business in the coming years.
Request For Customization
Enquiry Before Buying
Speak With Analyst
